Clinical trial · Interventional
Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer
Honey Based Syrup on Blood Parameters
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Study aim Determination of the effect of a honey based (HB) syrup on the blood parameters of patients with breast cancer Design Two arm parallel group randomised clinical trial, double blinded Settings and conduct Design of the study: Women patients with breast cancer referring to Shohaday-e- Tajrish Hospital of Tehran who are under chemotherapy treatment. In order to blind the investigator, medications are named as "A" for syrup of HB and B for placebo. The patients don't aware of the type of drug they are assigned to. In addition, the groups are entered into statistical analysis as "A" and "B. The patients will revive either A or B syrup for 4 weeks. At the beginning of the trial demographic data would be gathered. Also, a blood sample would be drawn at the beginning time and after the end of intervention period (week 4). Data would be analysed by SPSS software using T-test.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| honey based (HB) syrup | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Group A: patients receiving HB syrup, 10 cc three times daily
- interventionNames
- Drug: honey based (HB) syrup
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Group B: patients receiving placebo, 10 cc three times daily
- interventionNames
- Drug: honey based (HB) syrup
Primary outcomes (3)
- measure
- The change of mean score of Hemoglobin level of patients in intervention and placebo groups
- timeFrame
- The weeks of 0 and 4 after treatment
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Female gender * Age between 18- 70 years old Patients * known case of breast cancer * Hemoglobin level is at least 8 g / dl * Hematocrit level at least 30% The level of * TSH is normal Exclusion Criteria: * Patients known case of heart disease with unstable conditions * Disabling Pulmonary Disease and History of Asthma * Patients known case of severe kidney disease (Creatinine level is greater than 2mg / dl Proteinuria) * The SGOT level is more than 3 times of the normal threshold * Bilirubin levels is greater than 2mg / dl * Positive history of hypersensitivity to saffron, Rose water and Honey * Uncontrolled pain * severe infection * serious illness * Positive history of gout or high level of uric acid * An individual who uses antidepressants due to depression * Simultaneous use of drugs that affect blood cells * Unwillingness to participate in the study * Active treatment for anemia (transfusion or Epoetin Alfa Injection)
References
Publications (4)
- RESULTPasalar M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, Fattahi MR, Ghanizadeh A, Bagheri Lankarani K. Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial. Explore (NY). 2015 May-Jun;11(3):199-207. doi: 10.1016/j.explore.2015.02.007. Epub 2015 Feb 17. PMID 25777290
- RESULTPasalar M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, Fattahi MR, Zarshenas MM, Jafari P, Lankarani KB. Efficacy of jollab in the treatment of depression in dyspeptic patients: a randomized double-blind controlled trial. J Evid Based Complementary Altern Med. 2015 Apr;20(2):104-8. doi: 10.1177/2156587214563542. Epub 2015 Jan 13. PMID 25587004
- RESULTEmtiazy M, Oveidzadeh L, Habibi M, Molaeipour L, Talei D, Jafari Z, Parvin M, Kamalinejad M. Investigating the effectiveness of the Trigonella foenum-graecum L. (fenugreek) seeds in mild asthma: a randomized controlled trial. Allergy Asthma Clin Immunol. 2018 May 2;14:19. doi: 10.1186/s13223-018-0238-9. eCollection 2018. PMID 29743896
- RESULTTaavoni S, Fathi L, Nazem-Ekbatani N, Haghani H. The Effect of Oral Intake of Honey Syrup on the Pain Intensity of Active Phase of Parturition of nulliparous women: A Randomized clinical trial. Caspian J Intern Med. 2019 Winter;10(1):98-101. doi: 10.22088/cjim.10.1.98. PMID 30858948